Finance

Lists
Why is ANVS down 3.32%?
Dive Deeper
ANVS:NYSE
Annovis Bio Inc
$ 1.02
-3.32%
(-0.035) 1D
$ 1.06
+3.92% (+0.040)
After hours
Closed: 10-р сарын 14, 16:00:05 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
$ 1.05
High
$ 1.08
Low
$ 1.01
Mkt. cap
43.53 сая
Avg. vol.
1.20 сая
Volume
844.20 мян
52-wk high
$ 5.50
52-wk low
$ 1.01
EPS
-$ 1.78
Beta
1.23
Shares outstanding
42.68 сая
No. of employees
8
Open
$ 1.05
High
$ 1.08
Low
$ 1.01
Mkt. cap
43.53 сая
Avg. vol.
1.20 сая
Volume
844.20 мян
52-wk high
$ 5.50
52-wk low
$ 1.01
EPS
-$ 1.78
Beta
1.23
Shares outstanding
42.68 сая
No. of employees
8
News stories
From web sources and news partners
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Пеннсилвани, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current $ 1.02
$ 17.00 (+1,566.67%)
Average
$ 10.67 (+946.08%)
Lowest
$ 7.00 (+586.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$ 7.00
+586.3%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$ 17.00
+1,566.7%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$ 8.00
+684.3%
08/17/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$ 8.00
+684.3%
07/07/2026
Last report
2026 оны 8-р сарын 14
Fiscal period
Q2 2026
-$ 0.40 / -$ 0.46
+13.04%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.29 сая
8.75 сая
16.72 сая
12.01 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14 сая
955.15 мян
1.19 сая
2.37 сая
Operating expense
7.43 сая
9.71 сая
17.91 сая
14.38 сая
Total operating expenses
7.43 сая
9.71 сая
17.91 сая
14.38 сая
Operating income
-7.43 сая
-9.71 сая
-17.91 сая
-14.38 сая
Other non operating income
20.00 мян
-296.00 мян
268.00 мян
-603.34 мян
EBT including unusual items
-7.26 сая
-9.83 сая
-17.61 сая
-14.82 сая
EBT excluding unusual items
-7.26 сая
-9.83 сая
-17.51 сая
-14.82 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.26 сая
-9.83 сая
-17.61 сая
-14.82 сая
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.39
-0.63
-0.40
Interest and investment income
152.32 мян
167.74 мян
137.80 мян
160.23 мян
Interest expense
-
-
-
-
Net interest expenses
152.32 мян
167.74 мян
137.80 мян
160.23 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс